何承诚, 谢裕安, 毛赛兰, 黄正, 闫雷, 赵瑞强. PLXNC1 多态性与广西肝癌遗传易感的关系及其表达*[J]. 中国肿瘤临床, 2015, 42(13): 642-647. DOI: 10.3969/j.issn.1000-8179.20150397
引用本文: 何承诚, 谢裕安, 毛赛兰, 黄正, 闫雷, 赵瑞强. PLXNC1 多态性与广西肝癌遗传易感的关系及其表达*[J]. 中国肿瘤临床, 2015, 42(13): 642-647. DOI: 10.3969/j.issn.1000-8179.20150397
Chengcheng HE, Yu'an XIE, Sailan MAO, Zheng HUANG, Lei YAN, Ruiqiang ZHAO. Relationship of PLXNC1 (rs 2272335) polymorphism with genetic susceptibility to primary liver cancer among family clusters in Guangxi and its expression[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 42(13): 642-647. DOI: 10.3969/j.issn.1000-8179.20150397
Citation: Chengcheng HE, Yu'an XIE, Sailan MAO, Zheng HUANG, Lei YAN, Ruiqiang ZHAO. Relationship of PLXNC1 (rs 2272335) polymorphism with genetic susceptibility to primary liver cancer among family clusters in Guangxi and its expression[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 42(13): 642-647. DOI: 10.3969/j.issn.1000-8179.20150397

PLXNC1 多态性与广西肝癌遗传易感的关系及其表达*

Relationship of PLXNC1 (rs 2272335) polymorphism with genetic susceptibility to primary liver cancer among family clusters in Guangxi and its expression

  • 摘要: 目的:探讨PLXNC1 基因多态性与广西肝癌遗传易感性关系及表达。方法:以广西20个肝癌高发家族(肝癌家族组79例)和10个健康对照家族(健康对照组40例)为研究对象,应用飞行时间质谱技术检测两组中PLXNC1 基因rs 2272335 的基因型及等位基因频率,免疫组织化学染色检测PLXNC1 在不同肝组织中的表达。结果:PLXNC1 基因rs 2272335 位点健康对照组人群中携带C 等位基因型的个体发生干细胞肝癌(hepatocellularcarcinoma ,HCC )的风险分别是T 等位基因型个体的4.16倍(95%CI 为0.37~47.3),差异有统计学意义(P = 0.032)。核心成员组与 肝癌患者组两组间差异无统计学意义(P > 0.05)。PLXNC1 基因rs 2272335 位点基因型TT、TC、CC在肝癌患者组人群、核心成员组人群、健康对照组人群三组间者差异无统计学意义(P > 0.05)。 肝癌组织中,PLXNC1 蛋白表达水平3.12± 1.12显著高于肝癌癌旁组织1.54± 0.67和正常肝组织1.23± 0.87(P < 0.05)。结论:PLXNC1 基因rs 2272335 位点C 等位基因型可能是广西HCC 发生的危险因素。PLXNC1 过度表达与肝癌发生密切相关。

     

    Abstract: Objective:To investigate the correlation between plexinC 1 (PLXNC 1) rs 2272335 polymorphism and the family clus -tering genetic susceptibility to primary liver cancer (PLC) in Guangxi and the expression of PLXNC 1. Methods:Genotype and alleles of rs 2272335 were determined in 20liver cancer family groups ( 79cases) and 10healthy normal control groups (40cases) in Fusui County through Time of Flight Mass Spectrometer. Immunohistochemistry detected the PLEXNC1 protein expression. Results: For the alleles of PLXNC1 (rs 2272335) site, the risk of hepatocellular carcinoma (HCC) for individuals with C allele was 4.16-fold ( 95% CI = 0.37- 47.3, P=0.032) compared with that for individuals with T allele among the members of the healthy normal control group. The fre -quencies of the C and T alleles were similar in the HCC patients and the core individuals of liver cancer families (P>0.05). For the genotype of the PLXNC 1 (rs 2272335) site, the differences in frequencies of TT, TC, and CC genotypes were not statistically significant among the PLC patients and the core individuals of the liver cancer families and normal controls. The PLXNC 1 protein expression in HCC (3.12± 1.12) was higher than in hepatocellular paracancerous tissues ( 1.54± 0.67) and in benign hepatocellular lesions ( 1.23± 0.87) (P<0.05). Conclusion:The C allele of PLXNC1 (rs 2272335) site might be the risk gene for the occurrence of PLC family clustering in Guangxi. PLXNC1 protein overexpression was closely correlated with PLC oncogenesis.

     

/

返回文章
返回